Logo
Login
$SRRK
$42.49 +$0.78 (1.87%) Close

Company Executives

$SRRK Management Team

Ms. Tracey Sacco

Chief Commercial Officer

Age 48
Compensation $2.282M USD
Sex Female

Dr. Akshay Vaishnaw

President - Research & Development

Director

Age 62
Compensation $281.3K USD
Sex Male

Dr. Mo Qatanani

Chief Scientific Officer

Age 51
Compensation $2.959M USD
Sex Male

Ms. Junlin Ho

General Counsel

Corporate Secretary

Age 46
Compensation $2.128M USD
Sex Female

Dr. Adm. Jing Marantz

Chief Medical Officer

Age 59
Compensation $3.078M USD
Sex Female

Ms. Caryn Parlavecchio

Chief Human Resources Officer

Age 53
Compensation -
Sex Female

Mr. David Hallal

Chairman of the Board

Chief Executive Officer

Age 59
Compensation $400.8K USD
Sex Male

Mr. Vikas Sinha

Chief Financial Officer

Age 61
Compensation -
Sex Male

Mr. R. Keith Woods

Chief Operating Officer

Age 57
Compensation -
Sex Male

Ms. Lisa Wyman

Chief Technical and Quality Officer

Age 47
Compensation -
Sex Female

Ms. Beth Shafer

Chief Business Officer

Age 46
Compensation -
Sex Female

Board of Directors

From the proxy statement filed Apr 22, 2026
Directors
9
serving now
Independent
4 of 4
stated in the proxy; 5 not stated
Average tenure
7.2 years
from year joined
CEO also chairs the board
Yes
David Hallal
Director Age On board Independent Committees Other public boards 2025 pay Source
David Hallal
Board chair, CEO
 59 2017
9 years
 Not stated None stated ElevateBio, LLC, Kalaris Therapeutics, Inc. Paid as CEO
Kristina Burow
53 2014
12 years
 Not stated
Compensation Committee · Chair
Neumora Therapeutics, Inc., Boundless Bio, Inc., Mirador Therapeutics, Inc., Treeline Biosciences, Inc., Magnet Biomedicine, Inc. $531,049
Michael Gilman
71 2013
13 years
 Independent
Compensation Committee Science, Innovation and Technology Committee
None stated Not stated
Katie Peng
55 2024
2 years
 Not stated
Audit Committee Compensation Committee
Adicet Bio, Inc. $531,138
Richard Brudnick
69 2023
3 years
 Not stated
Audit Committee
InflaRx N.V. $524,524
Jeffrey S. Flier, M.D.
78 2016
10 years
 Independent None stated None stated $540,662
Akshay Vaishnaw, M.D., Ph.D.
Executive officer
 63 2019
7 years
 Not stated None stated Hemab Inc. Not stated
Srinivas Akkaraju, M.D., Ph.D.
58 2022
4 years
 Independent
Nominating and Corporate Governance Committee Science, Innovation and Technology Committee
Alumis, Inc., Mineralys Therapeutics Inc., vTv Therapeutics, Inc., Inventiva S.A., Kalaris Therapeutics, Inc. $526,027
Joshua Reed
53 2021
5 years
 Independent
Nominating and Corporate Governance Committee
None stated $540,052

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 22, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans